41
TITLE: Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study  Full Text
AUTHORS: Almeida, AM; Prebet, T; Itzykson, R; Ramos, F; Al Ali, H; Shammo, J; Pinto, R; Maurillo, L; Wetzel, J; Musto, P; Van De Loosdrecht, AA; Costa, MJ; Esteves, S; Burgstaller, S; Stauder, R; Autzinger, EM; Lang, A; Krippl, P; Geissler, D; Falantes, JF; Pedro, C; Bargay, J; Deben, G; Garrido, A; Bonanad, S; Diez Campelo, M; Thepot, S; Ades, L; Sperr, WR; Valent, P; Fenaux, P; Sekeres, MA; Greil, R; Pleyer, L; ...More
PUBLISHED: 2017, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 18, ISSUE: 4
INDEXED IN: Scopus WOS
IN MY: ORCID
42
TITLE: Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry  Full Text
AUTHORS: Almeida, AM; Bedrosian, C; Cole, A; Muus, P; Schrezenmeier, H; Szer, J; Rosse, WF;
PUBLISHED: 2017, SOURCE: INTERNAL MEDICINE JOURNAL, VOLUME: 47, ISSUE: 9
INDEXED IN: Scopus WOS
IN MY: ORCID
43
TITLE: Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study
AUTHORS: António Almeida; Ana Rita Ferreira; Maria João Costa; Sofia Silva; Khalil Alnajjar; Isabel Bogalho; Francesca Pierdomenico; Susana Esteves; Mafalda Alpoim; Gil Braz; Emilia Cortesão; Ricardo Pinto;
PUBLISHED: 2017, SOURCE: Leukemia Research Reports, VOLUME: 7
INDEXED IN: Scopus
IN MY: ORCID
44
TITLE: Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study
AUTHORS: António Almeida; Ana Rita Ferreira; Maria João Costa; Sofia Silva; Khalil Alnajjar; Isabel Bogalho; Francesca Pierdomenico; Susana Esteves; Mafalda Alpoim; Gil Braz; Emilia Cortesão; Ricardo Pinto;
PUBLISHED: 2017, SOURCE: Leukemia Research Reports, VOLUME: 7
INDEXED IN: CrossRef: 1
IN MY: ORCID
45
TITLE: Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry
AUTHORS: Antonio M Almeida; Camille Bedrosian; Alexander Cole; Petra Muus; Hubert Schrezenmeier; Jeff Szer; Wendell F Rosse;
PUBLISHED: 2017, SOURCE: Internal Medicine Journal, VOLUME: 47, ISSUE: 9
INDEXED IN: CrossRef: 17
IN MY: ORCID
46
TITLE: Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
AUTHORS: Antonio Almeida; Thomas Prebet; Raphael Itzykson; Fernando Ramos; Haifa Al-Ali; Jamile Shammo; Ricardo Pinto; Luca Maurillo; Jaime Wetzel; Pellegrino Musto; Arjan Van De Loosdrecht; Maria Costa; Susana Esteves; Sonja Burgstaller; Reinhard Stauder; Eva Autzinger; Alois Lang; Peter Krippl; Dietmar Geissler; Jose Falantes; Carmen Pedro; Joan Bargay; Guillermo Deben; Ana Garrido; Santiago Bonanad; Maria Diez-Campelo; Sylvain Thepot; Lionel Ades; Wolfgang Sperr; Peter Valent; Pierre Fenaux; Mikkael Sekeres; Richard Greil; Lisa Pleyer; ...More
PUBLISHED: 2017, SOURCE: International Journal of Molecular Sciences, VOLUME: 18, ISSUE: 4
INDEXED IN: CrossRef: 19
IN MY: ORCID
47
TITLE: Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
AUTHORS: Roboz, GJ; Montesinos, P; Selleslag, D; Wei, A; Jang, JH; Falantes, J; Voso, MT; Sayar, H; Porkka, K; Marlton, P; Almeida, A; Mohan, S; Ravandi, F; Garcia Manero, G; Skikne, B; Kantarjian, H;
PUBLISHED: 2016, SOURCE: FUTURE ONCOLOGY, VOLUME: 12, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
48
TITLE: Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents
AUTHORS: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stefanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Alberto Risueno; Kyle J MacBeth; Jianhua H Zhong; Francis Seguy; Albert Hoenekopp; Beach, CL; Pierre Fenaux; ...More
PUBLISHED: 2016, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 25
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
49
TITLE: Design and rationale of the QUAZAR lower-risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and poor prognosis due to red blood cell transfusion–dependent anemia and thrombocytopenia
AUTHORS: Guillermo Garcia Manero; Antonio Almeida; Aristoteles Giagounidis; Uwe Platzbecker; Regina Garcia; Maria Teresa Voso; Stephen R Larsen; David Valcarcel; Lewis R Silverman; Barry Skikne; Valeria Santini;
PUBLISHED: 2016, SOURCE: BMC Hematology, VOLUME: 16, ISSUE: 1
INDEXED IN: Scopus
IN MY: ORCID
50
TITLE: Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients
AUTHORS: Álvaro Urbano-Ispizua; Petra Muus; Hubert Schrezenmeier; Antonio M Almeida; Amanda Wilson; Russell E Ware;
PUBLISHED: 2016, SOURCE: Haematologica, VOLUME: 102, ISSUE: 3
INDEXED IN: CrossRef: 16
IN MY: ORCID
Page 5 of 9. Total results: 86.